Windtree Therapeutics Inc
Windtree Therapeutics, Inc., a biotechnology company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases. Its lead product candidate is istaroxime, which is in Phase 2b clinical trials for the treatment of acute decompensated heart failure, as well as for the treatment of early cardiogenic shock. The company also develops AEROSURF, an aerosolized KL4 sur… Read more
Windtree Therapeutics Inc (WINT) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.549x
Based on the latest financial reports, Windtree Therapeutics Inc (WINT) has a cash flow conversion efficiency ratio of 0.549x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-6.37 Million) by net assets ($-11.60 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Windtree Therapeutics Inc - Cash Flow Conversion Efficiency Trend (1995–2024)
This chart illustrates how Windtree Therapeutics Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Windtree Therapeutics Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Windtree Therapeutics Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Biofrontera Inc. Warrants
NASDAQ:BFRIW
|
1.481x |
|
Capital Trust Limited
NSE:CAPTRUST
|
0.201x |
|
Cheche Group Inc. Warrant
NASDAQ:CCGWW
|
-0.013x |
|
York Timber Holdings Ltd
JSE:YRK
|
0.025x |
|
Joshua Gold Resources Inc
PINK:JSHG
|
-0.004x |
|
Sylla Gold Corp.
PINK:SYGCF
|
0.000x |
|
Cartica Acquisition Corp Warrant
NASDAQ:CITEW
|
-0.008x |
|
Premier Biomedical Inc
PINK:BIEI
|
0.017x |
Annual Cash Flow Conversion Efficiency for Windtree Therapeutics Inc (1995–2024)
The table below shows the annual cash flow conversion efficiency of Windtree Therapeutics Inc from 1995 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $10.00 Million | $-15.40 Million | -1.541x | +61.12% |
| 2023-12-31 | $3.39 Million | $-13.44 Million | -3.963x | -103.95% |
| 2022-12-31 | $10.01 Million | $-19.45 Million | -1.943x | -243.85% |
| 2021-12-31 | $41.88 Million | $-23.66 Million | -0.565x | -55.24% |
| 2020-12-31 | $69.55 Million | $-25.32 Million | -0.364x | -10.59% |
| 2019-12-31 | $74.94 Million | $-24.66 Million | -0.329x | -42.06% |
| 2018-12-31 | $68.11 Million | $-15.78 Million | -0.232x | -126.33% |
| 2017-12-31 | $-23.92 Million | $-21.05 Million | 0.880x | -24.48% |
| 2016-12-31 | $-28.83 Million | $-33.59 Million | 1.165x | +128.74% |
| 2015-12-31 | $8.27 Million | $-33.50 Million | -4.053x | -89.02% |
| 2014-12-31 | $19.20 Million | $-41.17 Million | -2.144x | -210.09% |
| 2013-12-31 | $58.50 Million | $-40.45 Million | -0.692x | +62.88% |
| 2012-12-31 | $17.65 Million | $-32.88 Million | -1.863x | +89.63% |
| 2011-12-31 | $1.26 Million | $-22.70 Million | -17.957x | -345.86% |
| 2010-12-31 | $6.03 Million | $-24.27 Million | -4.028x | +34.08% |
| 2009-12-31 | $4.49 Million | $-27.41 Million | -6.110x | -110.38% |
| 2008-12-31 | $10.93 Million | $-31.75 Million | -2.904x | -283.16% |
| 2007-12-31 | $38.78 Million | $-29.39 Million | -0.758x | +72.74% |
| 2006-12-31 | $14.32 Million | $-39.83 Million | -2.781x | -67.99% |
| 2005-12-31 | $34.84 Million | $-57.67 Million | -1.655x | -4.74% |
| 2004-12-31 | $21.10 Million | $-33.34 Million | -1.580x | -63.71% |
| 2003-12-31 | $24.30 Million | $-23.46 Million | -0.965x | -6.06% |
| 2002-12-31 | $14.76 Million | $-13.44 Million | -0.910x | -26.31% |
| 2001-12-31 | $17.62 Million | $-12.70 Million | -0.721x | -102.25% |
| 2000-12-31 | $16.44 Million | $-5.86 Million | -0.356x | +73.23% |
| 1999-12-31 | $3.11 Million | $-4.14 Million | -1.331x | +31.49% |
| 1998-12-31 | $3.50 Million | $-6.80 Million | -1.943x | -319.66% |
| 1997-12-31 | $10.80 Million | $-5.00 Million | -0.463x | +64.73% |
| 1996-12-31 | $1.60 Million | $-2.10 Million | -1.313x | -89.00% |
| 1995-12-31 | $3.60 Million | $-2.50 Million | -0.694x | -- |